Deals
Glaxo Plans Sale of $3.7 Billion Stake in Unilever India
- Drugmaker working with advisers on block trades, people said
- Glaxo acquired Hindustan Unilever shares in asset sale
This article is for subscribers only.
GlaxoSmithKline Plc is preparing to start a sale of its $3.7 billion stake in Unilever’s listed India unit, according to people familiar with the matter.
Glaxo plans to offload part or all of its 5.7% holding in Hindustan Unilever Ltd. through a series of block trades, which could start as soon as the next few days, according to the people. The company is in discussions with advisers on when to launch the transactions, the people said, asking not to be identified because the information is private.